Home > M&A deals 2005 > Pfizer, Inc. acquires Bioren, Inc.
Add-on Acquistion · Life Science · August 2005

Pfizer, Inc. acquires Bioren, Inc.

On August 15, 2005, Pfizer, Inc. acquired Bioren, Inc., a life science company in California, United States, from Bay City Capital LLC.

Deal at a glance

AnnouncedAugust 15, 2005 TypeAdd-on Acquistion TargetBioren, Inc. Buyer Pfizer, Inc. Seller Bay City Capital LLC SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Bioren, Inc.
California, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Pfizer, Inc.
Company · 57 deals on record
  • 5th transaction in life science
  • 5th transaction in United States
57deals, all time
32in this sector
2022latest

Seller

Bay City Capital LLC
Private equity firm · 78 deals on record
78investments
51in this sector
53exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Biohaven Pharmaceutical Holding Co. Ltd.Same lead buyer · May 2022
ReViral Ltd.Same lead buyer · Apr 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Bioren, Inc.?Pfizer, Inc. acquired Bioren, Inc. on August 15, 2005.

Who sold Bioren, Inc.?Bay City Capital LLC was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2005.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).